Sai Parenterals Ltd., incorporated in 2001 and headquartered in Hyderabad, India, operates within the pharmaceutical industry. The company focuses on the research, development, manufacturing, and supply of pharmaceutical formulations with a specialization in parenteral products, including sterile injectables and large-volume parenterals. Its business segments encompass pharmaceutical formulations, parenteral products, and large-volume parenterals. Sai Parenterals serves the Indian market and is publicly listed on Indian stock exchanges, having completed its listing in April 2026. No subsidiaries, founders, or key management details have been disclosed.